Appointment of Contract Development and Manufacturing Organization (CDMO) for Vaccine Production
Public Health England (PHE) has awarded a contract to ABL Europe SAS to provide comprehensive services supporting vaccine development through its manufacturing. The project required establishing manufacturing conditions based on existing knowledge of Modified Vaccinia Ankara (MVA) viral vector production and quality control (QC) testing, to support Good Manufacturing Practice (GMP) release of drug product by end of Q1 / early Q2 2021. The contract was awarded following extensive market research and publication of V...
Buyer
Public Health England
Value
£1,250,000
Published
15 Jun 2020
Closes
31 Dec 2019
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
14 Jan 2020
Contract ends
31 Mar 2021
CPV classifications
73111000
Research laboratory services
Lots
Lot default Appointment of Contract Development and Manufacturing Organization (CDMO) for Vaccine Production
£1,250,000
Public Health England (PHE) has awarded a contract to ABL Europe SAS to provide comprehensive services supporting vaccine development through its manufacturing. The project required establishing manufacturing conditions based on existing knowledge of Modified Vaccinia Ankara (MVA) viral vector production and quality control (QC) testing, to support Good Manu...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
15 Jun 2020
Awarded contract notice on Contracts Finder
Award notice · Web page
Information about our Organisation
Not provided
Information about our Organisation
Tender notice
Contains public sector information licensed under the Open Government Licence v3.0.